The pre-diagnostic phase of Parkinson s

Size: px
Start display at page:

Download "The pre-diagnostic phase of Parkinson s"

Transcription

1 The pre-diagnostic phase of Parkinson s Disease Anthony Schapira London, UK GPSRC CNS RTG 1

2 Early diagnosis is it possible? Clinical i l evaluation Imaging Gene testing Biochemistry GPSRC CNS RTG 2

3 Early diagnosis does it matter? Diagnosis i for diagnosis i sake Testing neuroprotective drugs Prescribing neuroprotective drugs GPSRC CNS RTG 3

4 Pre-symptomatic period of PD? Clinical i l clues range from 3 8 years Pathological clues suggest 7 8 years Imaging g clues suggest 7 8 years Genetic causes can be decades GPSRC CNS RTG 4

5 Symptoms of PD Motor symptoms Rest tremor Rigidity Bradykinesia Non-motor symptoms Sensory phenomena Loss of smell REM behaviour disorder (RBD) Depression Dementia Autonomic dysfunction GPSRC CNS RTG 5

6 Diagnostic markers for PD Unilateral l onset (asymmetry) Bradykinesia Rigidity Resting tremor Good and sustained response to dopaminergic therapy GPSRC CNS RTG 6

7 Non-motor symptoms at presentation of PD 21% had only NMS at first visit it median to PD diagnosis i is 1.6 years vs 1.0 years Pain in 53% Urinary problems 16.5% Depression or anxiety 12% Non-specific cognitive impairment 5.5% No difference in time to hallucinations (10 years), dyskinesias (8 years), duration of PD to death (14 years) or age at death (75 years) O Sullivan et al. Mov Disord 2008;23: GPSRC CNS RTG 7

8 Diagnosis of PD Primary care and general physicans accuracy is about 60% Neurologist s s accuracy about 85% Movement disorder specialists: 99% (accuracy in first 4 years 75%) Hughes et al. Brain 2002;125: GPSRC CNS RTG 8

9 Pre-symptomatic markers of PD Olfactory loss Depression REM sleep disorder Constipation GPSRC CNS RTG 9

10 Hyposmia in PD 361 asymptomatic ti relatives of PD patients t 11% hyposmic (40 relatives) 18% of hyposmics (7 patients) had abnormal SPECT 5 patients had worse single photon emission computed tomography (SPECT) at 2 years 10% (n=4) of hyposmic 1 st degree relatives developed PD within 2 years ( 1% all relatives) Ponsen et al. Ann Neurol 2004;56: GPSRC CNS RTG 10

11 Conclusions Hyposmia in asymptomatic ti relatives of patients t with PD is associated with a 10% risk of developing PD Increased rate of binding decline in another 5 patients may increase the risk to as high as 22% Honolulu study: hyposmia <25% Odds ratio 5.2 (10/549); 25 50% Odds ratio 3.1 within 4 years Intact olfactory function lowers the risk of developing e PD (no higher than general population) Webster Ross et al. Ann Neurol 2007;63; GPSRC CNS RTG 11

12 Depression in PD Depression or panic attacks may precede the onset of motor symptoms in up to 44% Mean period of depression preceding PD was 5 years. Patients were younger, less impaired and had positive family history Santamaria et al. J Neurology 1986;36: GPSRC CNS RTG 12

13 Constipation as a risk factor for PD 24 years prospective follow-up data from 6790 men aged years 96 incident cases of PD Relative risk (RR) for PD (adjusted for age and risk factors) significantly increased in males with < 1 bowel movement per day vs 1 bowel movement per day: RR = 2.7 vs 2 bowel movements per day: RR = 4.1 vs > 2 bowel movements per day: RR = 4.5 Abbott et al. Neurology 2001;57: GPSRC CNS RTG 13

14 RBD and Parkinsonism Approx. 30% of PD may develop RBD Idiopathic RBD strongly associated with neurodegeneration: 19 38% at 5 years and 40 60% at 10 years approx. 50% PD PD patients with RBD: akinetic rigid type, more autonomic problems and cognitive impairment Gagnon et al. Lancet Neurol 2006;5:424 32; Iranzo et al. Lancet Neurol 2006;5:572 7; Schenck et al. Neurology 1996;46:388 93; Postuma et al. Neurology 2006;66: GPSRC CNS RTG 14

15 A UP PDRS Score UPDRS Part III B umber Alternate Tap Test N of Taps Alternate Tap Test RBD Control o RBD Control o C 20 Purdue PegBoard D 14 Timed Up and Go umber of Pegs N Time (S Seconds) RBD Control RBD Control Adapted from Postuma et al. Neurology 2006;66: GPSRC CNS RTG 15

16 Olfactory discrimination The speaker has requested that t this slide is not shown for copyright reasons GPSRC CNS RTG 16

17 Vision (colour) The speaker has requested that t this slide is not shown for copyright reasons GPSRC CNS RTG 17

18 Colour hue and other factors The speaker has requested that t this slide is not shown for copyright reasons GPSRC CNS RTG 18

19 Motor speed correlates with hyposmia The speaker has requested that t this slide is not shown for copyright reasons GPSRC CNS RTG 19

20 New interpretation of Braak hypothesis: PD is a prion disease The speaker has requested that t this slide is not shown for copyright reasons GPSRC CNS RTG 20

21 Favourable factors The speaker has requested that t this slide is not shown for copyright reasons GPSRC CNS RTG 21

22 Early diagnosis is it possible? Clinical i l evaluation Imaging Gene testing Biochemistry GPSRC CNS RTG 22

23 Early diagnosis is it possible? Clinical i l evaluation Imaging Gene testing Biochemistry GPSRC CNS RTG 23

24 Inherited Parkinsonism The speaker has requested that t this slide is not shown for copyright reasons GPSRC CNS RTG 24

25 LRRK2 mutation worldwide prevalence The speaker has requested that t this slide is not shown for copyright reasons GPSRC CNS RTG 25

26 Healy line graph The speaker has requested that t this slide is not shown for copyright reasons GPSRC CNS RTG 26

27 Healey Kaplan Meier Healy et al. Lancet Neurol 2008;7: GPSRC CNS RTG 27

28 Gluecocerbrosidase mutations The speaker has requested that t this slide is not shown for copyright reasons GPSRC CNS RTG 28

29 Early diagnosis is it possible? Clinical i l evaluation Imaging Gene testing Biochemistry (urate) GPSRC CNS RTG 29

30 Common pathways underlying PD pathogenesis The speaker has requested that t this slide is not shown for copyright reasons GPSRC CNS RTG 30

31 Early diagnosis is it possible? Clinical evaluation Imaging Gene testing Biochemistry GPSRC CNS RTG 31

32 Incidence rate line graph The speaker has requested that t this slide is not shown for copyright reasons GPSRC CNS RTG 32

33 Kempster graph The speaker has requested that t this slide is not shown for copyright reasons GPSRC CNS RTG 33

34 Conclusions Even with current criteria, diagnosis of PD is only 75% accurate at presentation Certain non-motor features precede motor deficits, but none are specific for PD Combinations help enrich a population, but numbers converting to PD are small Genetic factors are uncommon and penetrance variable Heterogenicity of PD aetiology will confound early markers Ultimately, PD risk will likely be estimated by a complex of genetic and phenotypic (clinical and biochemical) markers and imaging GPSRC CNS RTG 34

35 Copyright statements Slide 16 Slide , reproduced with permission from Wolters Kluwer Health 2008, reproduced with permission from Elsevier 35

What is PD? Dr Catherine Dotchin MD MRCP Consultant Geriatrician

What is PD? Dr Catherine Dotchin MD MRCP Consultant Geriatrician What is PD? Dr Catherine Dotchin MD MRCP Consultant Geriatrician Overview of presentation Case history Video example pre and post treatment Historical review PD in the UK Epidemiology and aetiology Making

More information

Unmet Needs for Parkinson s Disease Therapeutics

Unmet Needs for Parkinson s Disease Therapeutics Unmet Needs for Parkinson s Disease Therapeutics Coalition Against Major Diseases & FDA Workshop October 20, 2014 Caroline M Tanner MD, PhD Director, Parkinson's Disease Research Education and Clinical

More information

Mr James Garrard University of Leicester May 2014

Mr James Garrard University of Leicester May 2014 Parkinson s disease exemplifies the art and science of geriatric medicine. Introduction First described by Dr. James Parkinson in the classic essay The Shaking Palsy in 1817 (1), Parkinson s disease is

More information

Dementia & Movement Disorders

Dementia & Movement Disorders Dementia & Movement Disorders A/Prof Michael Davis Geriatrician ACT Health & GSAHS ANU Medical School Eastern Dementia Network Aged and Dementia Care Symposium Bateman s Bay, 22 October 2010 Types of Dementia

More information

Lewy body dementia Referral for a Diagnosis

Lewy body dementia Referral for a Diagnosis THE Lewy Body society The more people who know, the fewer people who suffer Lewy body dementia Referral for a Diagnosis Lewy Body Dementias REFERRAL FOR A DIAGNOSIS In the UK people with all forms of dementia

More information

Parkinson's s disease - a

Parkinson's s disease - a Parkinson's Disease Parkinson's s disease - a progressive disorder of the nervous system that affects movement. The most common perception of Parkinson s is the patient having tremors. Hands shaking, inability

More information

Parkinson s Disease - A Junior Doctor s Survival Guide

Parkinson s Disease - A Junior Doctor s Survival Guide Parkinson s Disease - A Junior Doctor s Survival Guide Professor Richard Walker Consultant Geriatrician Hon. Professor of Ageing & Interna

More information

PARKINSON S DISEASE AND PARKINSONISM. Dr Phil Wood Geriatrician, Waitemata DHB Clinical Unit Leader, Waikato DHB

PARKINSON S DISEASE AND PARKINSONISM. Dr Phil Wood Geriatrician, Waitemata DHB Clinical Unit Leader, Waikato DHB PARKINSON S DISEASE AND PARKINSONISM Dr Phil Wood Geriatrician, Waitemata DHB Clinical Unit Leader, Waikato DHB OUTLINE Covering:- Why this is an important area of Medical and Psychiatric care The variety

More information

Emergency Room Treatment of Psychosis

Emergency Room Treatment of Psychosis OVERVIEW The term Lewy body dementias (LBD) represents two clinical entities dementia with Lewy bodies (DLB) and Parkinson s disease dementia (PDD). While the temporal sequence of symptoms is different

More information

PARKINSON S DISEASE IN LONG-TERM-CARE SETTINGS

PARKINSON S DISEASE IN LONG-TERM-CARE SETTINGS PARKINSON S DISEASE IN LONG-TERM-CARE SETTINGS De Anna Looper, RN CHPN Corporate Clinical Consultant / Legal Nurse Consultant Carrefour Associates L.L.C. PARKINSON S DISEASE IN LONG-TERM-CARE SETTINGS

More information

Parkinson s prevalence in the United Kingdom (2009)

Parkinson s prevalence in the United Kingdom (2009) Parkinson s prevalence in the United Kingdom (2009) Contents Summary 3 Background 5 Methods 6 Study population 6 Data analysis 7 Results 7 Parkinson's prevalence 7 Parkinson's prevalence among males and

More information

SLEEP AND PARKINSON S DISEASE

SLEEP AND PARKINSON S DISEASE A Practical Guide on SLEEP AND PARKINSON S DISEASE MICHAELJFOX.ORG Introduction Many people with Parkinson s disease (PD) have trouble falling asleep or staying asleep at night. Some sleep problems are

More information

Parkinson s Disease: Factsheet

Parkinson s Disease: Factsheet Parkinson s Disease: Factsheet Tower Hamlets Joint Strategic Needs Assessment 2010-2011 Executive Summary Parkinson s disease (PD) is a progressive neuro-degenerative condition that affects a person s

More information

Current evidence suggests that Parkinson s tends to develop

Current evidence suggests that Parkinson s tends to develop About Parkinson's Diagnosing Parkinson s Current evidence suggests that Parkinson s tends to develop gradually and it may be many months, even years, before the symptoms become obvious enough for you to

More information

Parkinson's disease. Definition. Symptoms

Parkinson's disease. Definition. Symptoms Parkinson's disease Definition Parkinson's disease is a progressive disorder of the nervous system that affects your movement. It develops gradually, sometimes starting with a barely noticeable tremor

More information

Clinical Research in Parkinson s Disease: The Advances, Challenges, and Importance of Rater Training

Clinical Research in Parkinson s Disease: The Advances, Challenges, and Importance of Rater Training Clinical Research in Parkinson s Disease: The Advances, Challenges, and Importance of Rater Training Marian A. Ormont, MD epharmasolutions, A WIRB-Copernicus Group Company April is Parkinson s disease

More information

Parkinson s Disease Symptoms Guide

Parkinson s Disease Symptoms Guide Parkinson s Disease Symptoms Guide Some symptoms of Parkinson s disease (PD) are hard for even specialists to detect. Others are obvious even to an untrained eye. Parkinson s symptoms are different for

More information

Traumatic brain injury (TBI)

Traumatic brain injury (TBI) Traumatic brain injury (TBI) A topic in the Alzheimer s Association series on understanding dementia. About dementia Dementia is a condition in which a person has significant difficulty with daily functioning

More information

How To Treat An Elderly Patient

How To Treat An Elderly Patient 1. Introduction/ Getting to know our Seniors a. Identify common concepts and key terms used when discussing geriatrics b. Distinguish between different venues of senior residence c. Advocate the necessity

More information

Diagnosing Parkinson s disease (PD) in

Diagnosing Parkinson s disease (PD) in MedicineToday 2015; 16(1): 12-18 PEER REVIEWED FEATURE 2 CPD POINTS The clinical challenge of early Parkinson s disease SIMON J.G. LEWIS MB BCh, BSc, MRCP, FRACP, MD Early Parkinson s disease may be challenging

More information

Sleep Difficulties. Insomnia. By Thomas Freedom, MD and Johan Samanta, MD

Sleep Difficulties. Insomnia. By Thomas Freedom, MD and Johan Samanta, MD Sleep Difficulties By Thomas Freedom, MD and Johan Samanta, MD For most people, night is a time of rest and renewal; however, for many people with Parkinson s disease nighttime is a struggle to get the

More information

Understanding Parkinson s Disease

Understanding Parkinson s Disease Understanding Parkinson s Disease Irene Oh, MD Neurologist, Movement Disorders Specialist The Neurology Center of Southern California, Encinitas & Escondido Introduction PD was first described in 1817

More information

ABC s of Parkinson s Disease 4/29/15 Karen Parenti, MS, PsyD

ABC s of Parkinson s Disease 4/29/15 Karen Parenti, MS, PsyD ABC s of Parkinson s Disease 4/29/15 Karen Parenti, MS, PsyD What is Parkinson s Disease? Parkinson's disease is a progressive disorder of the nervous system that affects movement. It develops gradually,

More information

Parkinson s Disease: A Review of Motor and Nonmotor Symptoms

Parkinson s Disease: A Review of Motor and Nonmotor Symptoms Diana Hong Parkinson s Disease: A Review of Motor and Nonmotor Symptoms Abstract: Although Parkinson s disease (PD) is considered a motor system disorder caused by the degeneration of dopaminergic neurons

More information

HD 101 for newcomers. Martha A. Nance MD Hennepin County Medical Center HD COE Struthers Parkinson s Center

HD 101 for newcomers. Martha A. Nance MD Hennepin County Medical Center HD COE Struthers Parkinson s Center HD 101 for newcomers Martha A. Nance MD Hennepin County Medical Center HD COE Struthers Parkinson s Center The information provided by speakers in workshops, forums, sharing/networking sessions and any

More information

Version 1.1 1 18/04/11

Version 1.1 1 18/04/11 Department of Neurology Southern General Hospital 1345 Govan Road Glasgow G51 4TF PRoBaND: Parkinson's Repository of Biosamples and Networked Datasets Information Sheet for: Relatives of patients with

More information

Parkinson s Disease (PD)

Parkinson s Disease (PD) Parkinson s Disease (PD) Parkinson s disease (PD) is a movement disorder that worsens over time. About 1 in 100 people older than 60 has Parkinson s. The exact cause of PD is still not known, but research

More information

Primary Endpoints in Alzheimer s Dementia

Primary Endpoints in Alzheimer s Dementia Primary Endpoints in Alzheimer s Dementia Dr. Karl Broich Federal Institute for Drugs and Medical Devices (BfArM) Kurt-Georg-Kiesinger-Allee 38, D-53175 Bonn Germany Critique on Regulatory Decisions in

More information

Meeting the Needs of Aging Persons. Aging in Individuals with a

Meeting the Needs of Aging Persons. Aging in Individuals with a Meeting the Needs of Aging Persons with Developmental Disabilities Cross Network Collaboration for Florida Aging in Individuals with a Developmental Disability Module 3 Based on ADRC training developed

More information

Sinemet (Parkinson's Disease) - Forecast and Market Analysis to 2022

Sinemet (Parkinson's Disease) - Forecast and Market Analysis to 2022 Brochure More information from http://www.researchandmarkets.com/reports/2834728/ Sinemet (Parkinson's Disease) - Forecast and Market Analysis to 2022 Description: Sinemet (Parkinson s Disease) - Forecast

More information

1: Motor neurone disease (MND)

1: Motor neurone disease (MND) 1: Motor neurone disease (MND) This section provides basic facts about motor neurone disease (MND) and its diagnosis. The following information is an extracted section from our full guide Living with motor

More information

Tinnitus: a brief overview

Tinnitus: a brief overview : a brief overview sufferers experience sound in the absence of an external source. Sounds heard in tinnitus tend to be buzzing, hissing or ringing rather than fully-formed sounds such as speech or music.

More information

Steps to getting a diagnosis: Finding out if it s Alzheimer s Disease.

Steps to getting a diagnosis: Finding out if it s Alzheimer s Disease. Steps to getting a diagnosis: Finding out if it s Alzheimer s Disease. Memory loss and changes in mood and behavior are some signs that you or a family member may have Alzheimer s disease. If you have

More information

PARTNERS IN PARKINSON S. Parkinson s Disease Guide

PARTNERS IN PARKINSON S. Parkinson s Disease Guide PARTNERS IN PARKINSON S Parkinson s Disease Guide Each individual travels his or her own journey with Parkinson s disease, often encountering new challenges as symptoms progress and care needs change.

More information

PARKINSON S DISEASE INTRODUCTION. Parkinson s disease is defined as a disease of the nervous system that affects voluntary movement.

PARKINSON S DISEASE INTRODUCTION. Parkinson s disease is defined as a disease of the nervous system that affects voluntary movement. PARKINSON S DISEASE INTRODUCTION Parkinson s disease is a disorder of the brain and the nervous system. It is one of the more common neurological diseases in people over the age of 60, and it is more common

More information

Calendar of events NEUROLOGY

Calendar of events NEUROLOGY Calendar of events 2016 NEUROLOGY Rome, Italy 29 January 2016 Updates on MS treatment management Project an individualized treatment plan in MS Explain how to manage patients day to day issues List the

More information

Trauma Insurance Claims Seminar Invitation

Trauma Insurance Claims Seminar Invitation Trauma Insurance Claims Seminar Invitation Introduction Since the development of Trauma Insurance in Australia in the 1980s, the product has evolved at a great pace. Some of the challenges faced by claims

More information

Multiple Sclerosis: New Perspectives on the Patient Journey

Multiple Sclerosis: New Perspectives on the Patient Journey Multiple Sclerosis: New Perspectives on the Patient Journey Prepared by Milliman, Inc., NY Bruce Pyenson, FSA, MAAA Principal and Consulting Actuary Melissa Fredericks, FSA, MAAA Principal and Consulting

More information

MCDB 4777/5777 Molecular Neurobiology Lecture 38 Alzheimer s Disease

MCDB 4777/5777 Molecular Neurobiology Lecture 38 Alzheimer s Disease MCDB 4777/5777 Molecular Neurobiology Lecture 38 Alzheimer s Disease Outline of Today s Lecture Why is Alzheimer s disease a problem? What is Alzheimer s Disease? What causes Alzheimer s disease? How can

More information

Mental health issues in the elderly. January 28th 2008 Presented by Éric R. Thériault etheriau@lakeheadu.ca

Mental health issues in the elderly. January 28th 2008 Presented by Éric R. Thériault etheriau@lakeheadu.ca Mental health issues in the elderly January 28th 2008 Presented by Éric R. Thériault etheriau@lakeheadu.ca Cognitive Disorders Outline Dementia (294.xx) Dementia of the Alzheimer's Type (early and late

More information

06/06/2012. The Impact of Multiple Sclerosis in the Pacific Northwest. James Bowen, MD. Swedish Neuroscience Institute

06/06/2012. The Impact of Multiple Sclerosis in the Pacific Northwest. James Bowen, MD. Swedish Neuroscience Institute The Impact of Multiple Sclerosis in the Pacific Northwest James Bowen, MD Multiple Sclerosis Center Multiple Sclerosis Center Swedish Neuroscience Institute 1 2 Motor Symptoms of MS Weakness Spasticity

More information

Journal Club. Parkinsonismo iatrogeno

Journal Club. Parkinsonismo iatrogeno PROGETTO UNIVA 2013 Journal Club Parkinsonismo iatrogeno Pietro Gareri, MD, PhD Geriatra ASP Catanzaro Lamezia Terme 3 Luglio 2013 Drug-induced parkinsonism (DIP) was recognized in the early 1950s as a

More information

Rörelserubbningar och Parkinson, hur svårt kan det vara. En översikt och problematisering av en folksjukdom Örjan Skogar, MD,PhD

Rörelserubbningar och Parkinson, hur svårt kan det vara. En översikt och problematisering av en folksjukdom Örjan Skogar, MD,PhD Rörelserubbningar och Parkinson, hur svårt kan det vara En översikt och problematisering av en folksjukdom Örjan Skogar, MD,PhD Man räknar med att 11-19 personer /100 000 invånare insjuknar i Parkinson

More information

Dementia with Lewy bodies

Dementia with Lewy bodies IS 18 April 2011 Information sheet Dementia with Lewy bodies Introduction... 1 Key points... 1 What is dementia with Lewy bodies?... 1 How many people are affected by DLB?.. 2 What is the cause?... 2 Symptoms...

More information

Recognition and Treatment of Depression in Parkinson s Disease

Recognition and Treatment of Depression in Parkinson s Disease Recognition and Treatment of Depression in Parkinson s Disease Web Ross VA Pacific Islands Health Care System What is depression? Depression is a serious medical condition that affects a person s feelings,

More information

Clinically isolated syndrome (CIS)

Clinically isolated syndrome (CIS) Clinically isolated syndrome (CIS) Spirella Building, Letchworth, SG6 4ET 01462 476700 www.mstrust.org.uk reg charity no. 1088353 We hope you find the information in this factsheet helpful. If you would

More information

Patients with dementia and other types of structural brain injury are predisposed to delirium (i.e., abrupt onset, temporary confusion caused by

Patients with dementia and other types of structural brain injury are predisposed to delirium (i.e., abrupt onset, temporary confusion caused by Dementia is the permanent loss of multiple intellectual functions resulting from neuronal death. Dementia afflicts 10% of individuals over the age of 65 and these patients survive approximately seven years

More information

MOTION AND E-MOTION. Andrea Cavanna MD PhD FRCP

MOTION AND E-MOTION. Andrea Cavanna MD PhD FRCP MOTION AND E-MOTION Andrea Cavanna MD PhD FRCP Consultant in Behavioural Neurology, BSMHFT, Birmingham, UK Hon Professor in Neuropsychiatry, Aston University, Birmingham, UK Hon Reader in Neuropsychiatry,

More information

DISABILITY CLAIMS UNDER INSURANCE POLICIES

DISABILITY CLAIMS UNDER INSURANCE POLICIES DISABILITY CLAIMS UNDER INSURANCE POLICIES This article by our legal contributor and Information & Referral Associate is to assist persons living with Parkinson s in making claims for disability benefits

More information

Multiple System Atrophy guide (http://www.msaweb.co.uk/msaguide.htm)

Multiple System Atrophy guide (http://www.msaweb.co.uk/msaguide.htm) Multiple System Atrophy guide (http://www.msaweb.co.uk/msaguide.htm) Accessing information on Multiple System Atrophy (MSA) can be hard work. The Sarah Matheson Trust (SMT) produces a guide to MSA that

More information

PARKINSON SOCIETY CANADA NATIONAL RESEARCH PROGRAM. National Research Program 1

PARKINSON SOCIETY CANADA NATIONAL RESEARCH PROGRAM. National Research Program 1 PARKINSON SOCIETY CANADA NATIONAL RESEARCH PROGRAM National Research Program 1 Leading the way in Parkinson s research Research holds the key to unlock the mysteries of Parkinson s disease. Scientific

More information

Depression and Anxiety in Parkinson s disease

Depression and Anxiety in Parkinson s disease Depression and Anxiety in Parkinson s disease Greg Pontone, MD Director, Movement Disorders Psychiatry Clinical Programs at Johns Hopkins Morris K. Udall Parkinson's Disease Research Center Johns Hopkins

More information

6/3/2011. High Prevalence and Incidence. Low back pain is 5 th most common reason for all physician office visits in the U.S.

6/3/2011. High Prevalence and Incidence. Low back pain is 5 th most common reason for all physician office visits in the U.S. High Prevalence and Incidence Prevalence 85% of Americans will experience low back pain at some time in their life. Incidence 5% annual Timothy C. Shen, M.D. Physical Medicine and Rehabilitation Sub-specialty

More information

Graphical tasks to aid in diagnosing and monitoring Parkinson s disease

Graphical tasks to aid in diagnosing and monitoring Parkinson s disease Graphical tasks to aid in diagnosing and monitoring Parkinson s disease Esther J. Smits The studies described in this thesis were part of the DiPAR project for which funding was received from the EC in

More information

Welcome to the Medical Risk Webinar: a taster of Assessing and Managing Medical Risk for Insurers courses. 26 April 2013

Welcome to the Medical Risk Webinar: a taster of Assessing and Managing Medical Risk for Insurers courses. 26 April 2013 Welcome to the Medical Risk Webinar: a taster of Assessing and Managing Medical Risk for Insurers courses 26 April 2013 1 Parkinson s Disease & Multiple Sclerosis Dr Nick Niven Jenkins 2 Movement Human

More information

Disease Surveillance in New Jersey Spring 2006

Disease Surveillance in New Jersey Spring 2006 Creutzfeldt-Jakob Disease Surveillance in New Jersey Spring 2006 Shereen Brynildsen, MS Epidemiologist, Infectious & Zoonotic Disease Program New Jersey Department of Health & Senior Services Phone: 609-588

More information

Fit, (falls) and funny turns. Richard J Davenport Consultant Neurologist Edinburgh

Fit, (falls) and funny turns. Richard J Davenport Consultant Neurologist Edinburgh Fit, (falls) and funny turns Richard J Davenport Consultant Neurologist Edinburgh The plan Epilepsy nuggets 10 things I would like GPs to know This week s FS clinic What is epilepsy? Characterised by two

More information

1/25/2015. Idiopathic restless legs syndrome: clinical definition, pathophysiology and treatment. Five essential criteria (all must be met)

1/25/2015. Idiopathic restless legs syndrome: clinical definition, pathophysiology and treatment. Five essential criteria (all must be met) Idiopathic restless legs syndrome: clinical definition, pathophysiology and treatment Joan Santamaria, MD Neurology service, Multidisciplinary Sleep Disorders Unit Hospital Clínic de Barcelona University

More information

FUNCTIONAL EEG ANALYZE IN AUTISM. Dr. Plamen Dimitrov

FUNCTIONAL EEG ANALYZE IN AUTISM. Dr. Plamen Dimitrov FUNCTIONAL EEG ANALYZE IN AUTISM Dr. Plamen Dimitrov Preamble Autism or Autistic Spectrum Disorders (ASD) is a mental developmental disorder, manifested in the early childhood and is characterized by qualitative

More information

Alzheimer s disease. What is Alzheimer s disease?

Alzheimer s disease. What is Alzheimer s disease? Alzheimer s disease What is Alzheimer s disease? What we know about dementia and Alzheimer s disease Alzheimer s disease is the most common of a large group of disorders known as dementias. It is an irreversible

More information

REHABILITATION MEDICINE by PROFESSOR ANTHONY WARD

REHABILITATION MEDICINE by PROFESSOR ANTHONY WARD REHABILITATION MEDICINE by PROFESSOR ANTHONY WARD What is Rehabilitation Medicine? Rehabilitation Medicine (RM) is the medical specialty with rehabilitation as its primary strategy. It provides services

More information

Prostate Cancer Patients Report on Benefits of Proton Therapy

Prostate Cancer Patients Report on Benefits of Proton Therapy Prostate Cancer Patients Report on Benefits of Proton Therapy Dobson DaVanzo & Associates, LLC Vienna, VA 703.260.1760 www.dobsondavanzo.com Prostate Cancer Patients Report on Benefits of Proton Therapy

More information

An Introduction to Lewy Body Dementia

An Introduction to Lewy Body Dementia An Introduction to Lewy Body Dementia A special publication for people newly diagnosed with Lewy body dementia and those still seeking answers. You don t have to face LBD alone. Increasing Knowledge Sharing

More information

Prevalence of Parkinsonism and its aetiological subtypes within patients with movement disorders

Prevalence of Parkinsonism and its aetiological subtypes within patients with movement disorders Research papers Prevalence of and its aetiological subtypes within patients with movement disorders D G S V D Gajasinghe* AL 2002 batch of students, Faculty of Medicine, University of Colombo Abstract

More information

Alcohol Disorders in Older Adults: Common but Unrecognised. Amanda Quealy Chief Executive Officer The Hobart Clinic Association

Alcohol Disorders in Older Adults: Common but Unrecognised. Amanda Quealy Chief Executive Officer The Hobart Clinic Association Alcohol Disorders in Older Adults: Common but Unrecognised Amanda Quealy Chief Executive Officer The Hobart Clinic Association The Hobart Clinic Association Not-for-profit private Mental Health Service

More information

Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment

Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment Kinga Szigeti, MD Associate Professor UBMD Neurology UB Department of Neurology Questions How do we differentiate

More information

adaptations whenever possible, to prevent or reduce the occurrence of challenging behaviours.

adaptations whenever possible, to prevent or reduce the occurrence of challenging behaviours. POSITION STATEMENT on Management of Challenging Behaviours in People with Dementia 1. AIM OF THE POSITION STATEMENT This position statement applies to people living in supported accommodation and those

More information

International Journal of Economics, Commerce and Management United Kingdom Vol. II, Issue 2, 2014

International Journal of Economics, Commerce and Management United Kingdom Vol. II, Issue 2, 2014 International Journal of Economics, Commerce and Management United Kingdom Vol. II, Issue 2, 2014 http://ijecm.co.uk/ ISSN 2348 0386 HEALTHCARE MANAGEMENT AND PSYCHOLOGICAL WELL-BEING IN PATIENTS WITH

More information

Chemobrain. Halle C.F. Moore, MD The Cleveland Clinic October 3, 2015

Chemobrain. Halle C.F. Moore, MD The Cleveland Clinic October 3, 2015 Chemobrain Halle C.F. Moore, MD The Cleveland Clinic October 3, 2015 Terminology Chemotherapy-associated cognitive dysfunction Post-chemotherapy cognitive impairment Cancer treatment-associated cognitive

More information

Fatigue in MS: 2005 update B. Colombo University of Milan - HSR

Fatigue in MS: 2005 update B. Colombo University of Milan - HSR Fatigue in MS: 2005 update B. Colombo University of Milan - HSR Fatigue in MS One of the more disabling symptoms Affects about 75/90 % of the patients May be the onset symptom Transient or chronic May

More information

Cancer research in the Midland Region the prostate and bowel cancer projects

Cancer research in the Midland Region the prostate and bowel cancer projects Cancer research in the Midland Region the prostate and bowel cancer projects Ross Lawrenson Waikato Clinical School University of Auckland MoH/HRC Cancer Research agenda Lung cancer Palliative care Prostate

More information

Biomarkers for Alzheimer's Disease in Down Syndrome

Biomarkers for Alzheimer's Disease in Down Syndrome Biomarkers for Alzheimer's Disease in Down Syndrome Brad Christian, Ph.D. Waisman Laboratory for Brain Imaging Outline Rationale for Studying AD in Down Syndrome Background of Alzheimer s Disease Biomarkers

More information

A Definition of Multiple Sclerosis

A Definition of Multiple Sclerosis English 182 READING PRACTICE by Alyx Meltzer, Spring 2009 Vocabulary Preview (see bolded, underlined words) gait: (n) a particular way of walking transient: (adj) temporary; synonym = transitory remission:

More information

CBT IN THE CITY. adjusted to the news of being with MS? April 2013. Experts at your fingertips call now. Check out our new services in you local area

CBT IN THE CITY. adjusted to the news of being with MS? April 2013. Experts at your fingertips call now. Check out our new services in you local area April 2013 Experts at your fingertips call now CBT IN THE CITY Check out our new services in you local area contents. A message from Susie, Information Multiple Sclerosis CBT can make a difference on the

More information

NEUROLOGICAL REVIEW SECTION EDITOR: DAVID E. PLEASURE, MD. Predicting Motor Decline and Disability in Parkinson Disease

NEUROLOGICAL REVIEW SECTION EDITOR: DAVID E. PLEASURE, MD. Predicting Motor Decline and Disability in Parkinson Disease SECTION EDITOR: DAVID E. PLEASURE, MD Predicting Motor Decline and Disability in Parkinson Disease A Systematic Review NEUROLOGICAL REVIEW Connie Marras, MD; Paula Rochon, MD, MPH; Anthony E. Lang, MD

More information

J/601/2874. This unit must be assessed in accordance with Skills for Care and Development s QCF Assessment Principles.

J/601/2874. This unit must be assessed in accordance with Skills for Care and Development s QCF Assessment Principles. Unit 13: Dementia Awareness Unit code: DEM 201 Unit reference number: J/601/2874 QCF level: 2 Credit value: 2 Guided learning hours: 17 Unit summary The aim of the unit is to enable learners to gain knowledge

More information

Management of Parkinson s Disease in Primary Care

Management of Parkinson s Disease in Primary Care Management of Parkinson s Disease in Primary Care Dr June Tan National University Hospital System (NUHS) Division of Neurology Senior Consultant Topics: Diagnosing PD Choice of medication in the de novo

More information

Multiple Sclerosis Society of Canada. CADA Presentation May 4, 2011

Multiple Sclerosis Society of Canada. CADA Presentation May 4, 2011 Multiple Sclerosis Society of Canada CADA Presentation May 4, 2011 1 MS Society s Mission To be a leader in finding a cure for multiple sclerosis and enabling people affected by MS to enhance their quality

More information

Asymptomatic HIV-associated Neurocognitive Disorder (ANI) Increases Risk for Future Symptomatic Decline: A CHARTER Longitudinal Study

Asymptomatic HIV-associated Neurocognitive Disorder (ANI) Increases Risk for Future Symptomatic Decline: A CHARTER Longitudinal Study Asymptomatic HIV-associated Neurocognitive Disorder (ANI) Increases Risk for Future Symptomatic Decline: A CHARTER Longitudinal Study Robert Heaton, PhD 1, Donald Franklin, BS 1, Steven Woods, PsyD 1,

More information

How To Write Long Term Care Insurance

How To Write Long Term Care Insurance By Lori Boyce, AVP Risk Management and R&D Underwriting long term care insurance: a primer Every day Canadians die, are diagnosed with cancer, have heart attacks and become disabled and our insurance solutions

More information

Teen Misuse and Abuse of Alcohol and Prescription Drugs. Information for Parents

Teen Misuse and Abuse of Alcohol and Prescription Drugs. Information for Parents Teen Misuse and Abuse of Alcohol and Prescription Drugs Information for Parents Terminology Misuse: Using a drug in a way in which it was not intended Example: Using a higher dose of medication than was

More information

Alzheimer's: The Latest Assessment and Treatment Strategies

Alzheimer's: The Latest Assessment and Treatment Strategies Questions from chapter 1 Alzheimer's: The Latest Assessment and Treatment Strategies 1) What is a loss of cognitive and intellectual powers without changes in consciousness. a) dementia b) delusions c)

More information

Depression in Older Persons

Depression in Older Persons Depression in Older Persons How common is depression in later life? Depression affects more than 6.5 million of the 35 million Americans aged 65 or older. Most people in this stage of life with depression

More information

Depression and its Treatment in Older Adults. Gregory A. Hinrichsen, Ph.D. Geropsychologist New York City

Depression and its Treatment in Older Adults. Gregory A. Hinrichsen, Ph.D. Geropsychologist New York City Depression and its Treatment in Older Adults Gregory A. Hinrichsen, Ph.D. Geropsychologist New York City What is Depression? Everyday use of the word Clinically significant depressive symptoms : more severe,

More information

CLINICAL PRACTICE GUIDELINES FOR PHYSICAL THERAPY IN PATIENTS WITH PARKINSON'S DISEASE

CLINICAL PRACTICE GUIDELINES FOR PHYSICAL THERAPY IN PATIENTS WITH PARKINSON'S DISEASE CLINICAL PRACTICE GUIDELINES FOR PHYSICAL THERAPY IN PATIENTS WITH PARKINSON'S DISEASE Charbel MACARI Physical Therapist, AUBMC Master in Neurological Rehabilitation OUTLINE Definition, Epidemiology and

More information

Outcome of in-patient Treatment for Severe Motor Conversion Disorder - does it work? A.S.David, R.McCormack and Lishman Unit MDT

Outcome of in-patient Treatment for Severe Motor Conversion Disorder - does it work? A.S.David, R.McCormack and Lishman Unit MDT Outcome of in-patient Treatment for Severe Motor Conversion Disorder - does it work? A.S.David, R.McCormack and Lishman Unit MDT Evidence to date: inpatient rehab Inpatient multi-disciplinary intervention

More information

Guide to Assessment Scales in Parkinson s Disease

Guide to Assessment Scales in Parkinson s Disease Guide to Assessment Scales in Parkinson s Disease Pablo Martinez-Martin Research Unit, Alzheimer Centre Reina Sofia Foundation and Centre for Networked Biomedical Research on Neurodegenerative Diseases

More information

Tourette syndrome and co-morbidity

Tourette syndrome and co-morbidity Tourette syndrome and co-morbidity Nanette M.M. Mol Debes, M.D., Ph.D. Tourette clinic, Herlev University Hospital, Denmark Outline of presentation Research project Herlev University Hospital Denmark Prevalence

More information

NEURON AND NEURAL TRAMSMISSION: ANATOMY OF A NEURON. created by Dr. Joanne Hsu

NEURON AND NEURAL TRAMSMISSION: ANATOMY OF A NEURON. created by Dr. Joanne Hsu NEURON AND NEURAL TRAMSMISSION: ANATOMY OF A NEURON NEURON AND NEURAL TRAMSMISSION: MICROSCOPIC VIEW OF NEURONS A photograph taken through a light microscope (500x) of neurons in the spinal cord. NEURON

More information

Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) (APA, 2001) 10

Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) (APA, 2001) 10 5. Diagnosis Questions to be answered: 5.1. What are the diagnostic criteria for ADHD in children and adolescents? 5.2. How is ADHD diagnosed in children and adolescents? Who must diagnose it? 5.3. Which

More information

Research 2004-2006. Theresa A. Zesiewicz, MD FAAN Parkinson s Disease and Movement Disorders Center USF

Research 2004-2006. Theresa A. Zesiewicz, MD FAAN Parkinson s Disease and Movement Disorders Center USF Research 2004-2006 Theresa A. Zesiewicz, MD FAAN Parkinson s Disease and Movement Disorders Center USF 1. Essential Tremor Most common adult movement disorder in the world 1. Zesiewicz TA, Elble R, Louis

More information

The Burden of Pain Among Adults in the United States

The Burden of Pain Among Adults in the United States P F I Z E R F A C T S The Burden of Pain Among Adults in the United States Findings from the National Health and Nutrition Examination Survey, the National Health Care Surveys, and the National Health

More information

Cerebral palsy can be classified according to the type of abnormal muscle tone or movement, and the distribution of these motor impairments.

Cerebral palsy can be classified according to the type of abnormal muscle tone or movement, and the distribution of these motor impairments. The Face of Cerebral Palsy Segment I Discovering Patterns What is Cerebral Palsy? Cerebral palsy (CP) is an umbrella term for a group of non-progressive but often changing motor impairment syndromes, which

More information

09/05/2014. Painting pictures of the brain with numbers. Overview

09/05/2014. Painting pictures of the brain with numbers. Overview Painting pictures of the brain with numbers Neurology for Insurers Dr Ian Cox & Adele Groyer (Gen Re) Overview Critical Illness Product Background Why should we be interested in neurology? Consult our

More information

Intellectual Symptoms Amnesia: Loss of memory function

Intellectual Symptoms Amnesia: Loss of memory function Definition of Dementia (de mens) Latin for out of mind Permanent loss of multiple intellectual functions Alois Alzheimer first described this disease in 1906 in a brain specimen from an autopsy. Alzheimer

More information

symptoms of Incontinence

symptoms of Incontinence Types, causes and symptoms of Urinary Incontinence Aims and Objectives Aim: To have an understanding of the types and causes of urinary incontinence. Objectives: To be aware of the incidence and prevalence

More information

FastTest. You ve read the book... ... now test yourself

FastTest. You ve read the book... ... now test yourself FastTest You ve read the book...... now test yourself To ensure you have learned the key points that will improve your patient care, read the authors questions below. The answers will refer you back to

More information

Cerebral palsy, neonatal death and stillbirth rates Victoria, 1973-1999

Cerebral palsy, neonatal death and stillbirth rates Victoria, 1973-1999 Cerebral Palsy: Aetiology, Associated Problems and Management Lecture for FRACP candidates July 2010 Definitions and prevalence Risk factors and aetiology Associated problems Management options Cerebral

More information

ADHD AND ANXIETY AND DEPRESSION AN OVERVIEW

ADHD AND ANXIETY AND DEPRESSION AN OVERVIEW ADHD AND ANXIETY AND DEPRESSION AN OVERVIEW A/Professor Alasdair Vance Head, Academic Child Psychiatry Department of Paediatrics University of Melbourne Telephone: 9345 4666 Facsimile: 9345 6002 Email:

More information

Social Security Disability Insurance and young onset dementia: A guide for employers and employees

Social Security Disability Insurance and young onset dementia: A guide for employers and employees Social Security Disability Insurance and young onset dementia: A guide for employers and employees What is Social Security Disability Insurance? Social Security Disability Insurance (SSDI) is a payroll

More information